The miR Sentinel™ Prostate Cancer Test is commercially available in most US states as well as Puerto Rico. The Test is not currently available in New York, California, Pennsylvania, Maryland and Washington D.C. We are working to bring miR Sentinel™ to all 50 U.S. states, all territories and global markets including Canada, Israel, and select Asian markets.

If you would like to be added to our contact list to receive updates about expanded availability, please complete the contact information form at https://www.mirscientific.com/contact.